ZYLOS

Serial Number 87371723
Registration 5576644
702

Registration Progress

Application Filed
Mar 15, 2017
Under Examination
Feb 20, 2018
Approved for Publication
Jun 13, 2017
Published for Opposition
Jun 13, 2017
Registered
Oct 2, 2018

Basic Information

Serial Number
87371723
Registration Number
5576644
Filing Date
March 15, 2017
Registration Date
October 2, 2018
Published for Opposition
June 13, 2017
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
702
Status Date
Apr 1, 2024
Registration
Registered
Classes
005

Rights Holder

DAUUS CORPORATION

03
Address
3800 AMERICAN BLVD. WEST
SUITE 1500
BLOOMINGTON, MN 55431

Ownership History

Dauus Company LLC

Original Applicant
16
Bloomington, MN

Dauus Company LLC

Owner at Publication
16
Bloomington, MN

Dauus Company LLC

Original Registrant
16
Bloomington, MN

DAUUS CORPORATION

New Owner After Registration #1
03
BLOOMINGTON, MN

Legal Representation

Attorney
Julie Finch
USPTO Deadlines 2 active 2 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB Jul 13, 2017 2916 days overdue Medium Until Aug 13, 2017
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Aug 20, 2018 2513 days overdue High Until Feb 20, 2019

Application History

28 events
Date Code Type Description
Apr 1, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 1, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 1, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 5, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 2, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 4, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 21, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 5, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 30, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 29, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 28, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 28, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 31, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 31, 2018 IUAF S USE AMENDMENT FILED
Feb 20, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 8, 2018 APET A ASSIGNED TO PETITION STAFF
Jan 8, 2018 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Dec 21, 2017 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 13, 2017 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 13, 2017 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 13, 2017 PUBO A PUBLISHED FOR OPPOSITION
Jun 13, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2017 DOCK D ASSIGNED TO EXAMINER
Mar 21, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; all of the foregoing excluding pharmaceutical preparations and substances for the treatment and/or management of, the central nervous system, sleep disorders, cognitive disorders, fibromyalgia, insomnia, narcolepsy, and neurological or psychiatric diseases or disorders
First Use Anywhere: Jul 5, 2018
First Use in Commerce: Jul 5, 2018

Classification

International Classes
005